Moreover, as a key regulatory pathway in lung cancer cell growth, the EGFR signalling pathway can amplify signals through downstream cascade reactions, potentially resulting in more pronounced effects on downstream proteins compared to EGFR itself. The gene discussed is EGFR; the disease is lung cancer.